Allstate (NYSE:ALL) Price Target Raised to $228.00 at Morgan Stanley
Allstate (NYSE:ALL – Free Report) had its price objective upped by Morgan Stanley from $220.00 to $228.00 in a report issued on Thursday morning,Benzinga reports. They currently have an overweight rating on the insurance provider’s stock. Several other research analysts have also recently issued reports on ALL. Bank of America upped their target price on […]
More Stories
Venture Global (NYSE:VG) & Excelerate Energy (NYSE:EE) Financial Comparison
Excelerate Energy (NYSE:EE – Get Free Report) and Venture Global (NYSE:VG – Get Free Report) are both oils/energy companies, but...
Head to Head Analysis: Arbor Realty Trust (NYSE:ABR) & Apollo Commercial Real Estate Finance (NYSE:ARI)
Arbor Realty Trust (NYSE:ABR – Get Free Report) and Apollo Commercial Real Estate Finance (NYSE:ARI – Get Free Report) are...
Comparing TNF Pharmaceuticals (NASDAQ:TNFA) and Trinity Biotech (NASDAQ:TRIB)
Insider & Institutional Ownership 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares...
Head-To-Head Comparison: SMC Entertainment (OTCMKTS:SMCE) versus Marin Software (NASDAQ:MRIN)
Valuation and Earnings This table compares SMC Entertainment and Marin Software”s top-line revenue, earnings per share (EPS) and valuation. Gross...
Head-To-Head Survey: W. P. Carey (NYSE:WPC) versus Phillips Edison & Company, Inc. (NASDAQ:PECO)
W. P. Carey (NYSE:WPC – Get Free Report) and Phillips Edison & Company, Inc. (NASDAQ:PECO – Get Free Report) are...
Reviewing SolarBank (SUUN) & Its Competitors
SolarBank (NASDAQ:SUUN – Get Free Report) is one of 29 public companies in the “Electric & other services combined” industry,...